APA (7th ed.) Citation

Alexander, N., Giraldo‐Parra, L., Rebellón‐Sánchez, D. E., & Gómez, M. A. (2026). Modelling immune gene expression profiles as pharmacodynamic endpoints of antileishmanial treatment. British Journal of Clinical Pharmacology, 1. https://doi.org/10.1002/bcp.70675

Chicago Style (17th ed.) Citation

Alexander, Neal, Lina Giraldo‐Parra, David E. Rebellón‐Sánchez, and María Adelaida Gómez. "Modelling Immune Gene Expression Profiles as Pharmacodynamic Endpoints of Antileishmanial Treatment." British Journal of Clinical Pharmacology 2026: 1. https://doi.org/10.1002/bcp.70675.

MLA (9th ed.) Citation

Alexander, Neal, et al. "Modelling Immune Gene Expression Profiles as Pharmacodynamic Endpoints of Antileishmanial Treatment." British Journal of Clinical Pharmacology, 2026, p. 1, https://doi.org/10.1002/bcp.70675.